Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 14,084

Document Document Title
WO/2013/083225
The invention relates to the use of specific glucuronolactone derivates as self-tanning substances, as tanning intensifiers for dihydroxyacetone or for a mixture of self-tanning substances containing dihydroxyacetone for modulation of th...  
WO/2013/083225
The invention relates to the use of specific glucuronolactone derivates as self-tanning substances, as tanning intensifiers for dihydroxyacetone or for a mixture of self-tanning substances containing dihydroxyacetone for modulation of th...  
WO/2013/083994
The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.  
WO/2013/085999
Described is a process to make hydroxymethylfurfural (HMF) from glucose. The process includes the steps of reacting a feedstock solution comprising glucose, in the presence of a homogeneous Bransted acid catalyst and a homogeneous Lewis ...  
WO/2013/085824
The present invention provides compounds having the general structural Formula (I): and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutica...  
WO/2013/079022
The present invention relates to the field of natural drugs and pharmaceutical chemistry, and more particularly to novel 2-aminated methylene or 2-esterified methylene tanshinone I derivatives of a general formula I or pharmaceutically a...  
WO/2013/079819
A method for preparing ketose sugars, characterised in that: 1/ at least one aldose sugar or a solution or a suspension of said sugar in water is solubilised, in at least one organic solvent; 2/ the organic solution obtained is brought i...  
WO/2013/079866
The invention relates to a method for preparing 5-amino-benzoyl-benzofuran derivatives having the general formula in which R1 is hydrogen or an alkyl or aryl group and R2 is hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group. Accordi...  
WO/2013/079017
The present invention relates to the field of natural drugs and pharmaceutical chemistry, and more particularly to novel 2-alkyl-or-aryl-substituted tanshinone I derivatives of a general formula I or pharmaceutically acceptable salts the...  
WO/2013/080742
Provided is a method for efficiently manufacturing monosaccharides, oligosaccharides, and furfurals from biomass. While continuously supplying an aqueous biomass suspension via a supply port of a continuous primary hydrolysis device and ...  
WO/2013/077385
An aromatic amine derivative represented by the general formula (1). In the general formula (1), R1-R5 and R7-R11 are each independently hydrogen atoms or substituents. In the general formula (1), R6 and R12 are represented by the genera...  
WO/2013/075399
Provided in the present invention are an unsaturated 5-membered benzo-heterocyclic compound with the structure as shown in general formula I or pharmaceutical salts thereof, and a preparation method, a pharmaceutical composition and the ...  
WO/2013/075596
The present invention relates to the synthesis and use of a pentabasic dihydrogen heterocyclic ketone derivative of general formula (I) used as a DHODH inhibitor for Plasmodium falciparum, and the compound related to the present inventio...  
WO/2013/075253
The present application provides compound of Formula (X) wherein A is an optionally substituted aliphatic or an optionally substituted aryl, and B is a moiety that stabilizes the partial positive charge at the carbon adjacent the divalen...  
WO/2013/076747
A process is described for the production of 1,4-butanediol and tetrahydrofuran by catalytic hydrogenation of dialkyl maleates. The process consists essentially in the following steps: a) hydrogenating a stream of dialkyl maleate in a fi...  
WO/2013/077405
Provided is an aromatic amine derivative represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general formu...  
WO/2013/077406
Provided is an aromatic amine derivatives represented by general formula (1). In general formula (1), R2 to R5, R7 to R9, and R10 are each a hydrogen atom or a substituent. R1 and R6 in general formula (1) are represented by general form...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/072830
The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phth...  
WO/2013/069646
The purpose of the invention is to provide a polyimide offering excellent solubility in organic solvents, an acid dianhydride compound that is a monomer thereof, and a method for producing the same. An acid dianhydride represented by for...  
WO/2013/067578
Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated card...  
WO/2013/066776
Processes for producing 5-(hydroxymethyl)furfural are provided. 5-(hydroxymethyl)furfural is a potential platform intermediate in the conversion of biomass to renewable chemicals. The processes use hexoses in an aqueous solution comprisi...  
WO/2013/066541
Processes for producing furfural from biomass are provided. The processes use a metal halide in aqueous solutions of water-miscible and can provide a furfural yield of greater than 70%.  
WO/2013/064610
The invention relates to a process for the production of gamma-valerolactone (GVL) by gas phase hydrogenation of furfural or furfuryl alcohol in the presence of a solid catalyst. The conversion of furfural or furfuryl alcohol to GVL is c...  
WO/2013/064751
The present invention relates to a method and an arrangement for separation and recovery of at least one carboxylic acid and furfural from a dilute aqueous mixture thereof. In the method of the present invention a dilute aqueous mixture ...  
WO/2013/065835
A compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. This novel compound has an ability of activating a glycogen synthase, but rarely activates a receptor, i.e., a PPAR, and is highly safe. (In the...  
WO/2013/061724
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/061962
The present invention provides a compound represented by formula (I) or a salt thereof. (In the formula, the symbols are as defined in the description.)  
WO/2013/060860
The present invention relates to compounds having the general formula (I) as described herein; methods of preparing said compounds; and their use in treating Type 1 and/or Type 2 Diabetes Mellitus. The compounds were assayed for binding ...  
WO/2013/061004
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to the following general formula (I): , to the pharmaceutical compositions containing these compounds and also to the use of...  
WO/2013/061224
The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.  
WO/2013/061004
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to the following general formula (I): , to the pharmaceutical compositions containing these compounds and also to the use of...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/059215
Disclosed herein are substituted biaryl alkyl amide compounds, methods of synthesizing substituted biaryl alkyl amide compounds and methods of treating diseases and/or conditions with substituted biaryl alkyl amide compounds.  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/053046
The present application, relates to iron bisphenolate complexes and methods of use and synthesis thereof. The iron complexes are prepared from tridentate or tetradentate ligands of Formula I: wherein R1 and R2 are as defined herein. Also...  
WO/2013/053287
(-)-(S)-3-(3'-hydroxy)-butylphthalide (a compound shown by Formula I) and an ester formed of the same and an acid are proved by experiments to be applicable to treatment and prevention of cerebral ischemic diseases and have a sleep-impro...  
WO/2013/053816
The present invention relates to a process for producing 5-hydroxymethylfurfural (HMF) from fructose in a single-phase aqueous solution comprising an organic solvent.  
WO/2013/055577
The present invention provides novel selective androgen receptor modulators and their salts and pharmaceutical compositions thereof.  
WO/2013/050301
The present invention relates to processes for the enantio-selective preparation of spyrrolidine derivatives useful in the manufacture of pesticidally active compounds, as well as to intermedates in the processes. The processes include t...  
WO/2013/044371
A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R1 is i...  
WO/2013/047904
The present invention provides a novel compound having a control efficacy on harmful arthropods. A compound represented by Formula (I): wherein Y represents a 3-7-membered saturated heterocyclic group containing one or more atoms or grou...  
WO/2013/049711
Provided are methods of producing 2,5-furandicarboxylic acid (FDCA) from renewable sources such as seaweed, alginate, oligoalginate, pectin, oligopectin, polygalacturonate, galacturonate, and/or oligogalacturonate. The sugars in the rene...  
WO/2013/047055
Provided is a heat shock protein expression inducer based on a heat shock protein (HSP) expression-inducing action. The present invention is a heat shock protein (HSP) expression inducer comprising eupalinolide A and/or B, the heat shock...  
WO/2013/047044
The present invention is a composition for forming a film for liquid-immersion exposure, said composition containing the following: a polymer component (A) containing a polymer (a1) that has a constitutional unit (I) represented by diagr...  
WO/2013/047984
The present invention relates to a method for producing a furan-based compound using an ion exchange resin in the presence of an organic solvent. In the method for producing a furan-based compound according to the present invention, a fu...  
WO/2013/042769
This aromatic amine derivative is represented by general formula (1). In general formula (1), R2, R3, R4, R5, R7, R8, R9, and R10 each independently are a hydrogen atom or a substituent group. In general formula (1): R1 and R6 are repres...  

Matches 301 - 350 out of 14,084